VolitionRx Limited (VNRX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by VolitionRx Limited on June 18, 2026, covering events occurring on June 17, 2026. The Company is incorporated in Delaware and its common stock trades on NYSE American under the symbol "VNRX".
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or margin data. The report focuses exclusively on a specific debt repayment transaction involving equity issuance.
- Debt Instrument: Senior secured convertible promissory note with an original principal of $7,500,000 issued to Lind Global Asset Management XII LLC ("Lind").
- Recent Equity Issuance (June 17, 2026): 333,332 shares of common stock issued to satisfy a $416,666 payment obligation.
- Prior Equity Issuance (May 19, 2026): 212,259 shares of common stock issued to satisfy a $416,666 payment obligation.
Material Changes
The material change reported is the conversion of debt obligations into equity. The Company satisfied two separate payment obligations totaling $833,332 by issuing an aggregate of 545,591 shares of common stock to the existing securityholder, Lind, rather than through cash payments.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure of the transaction. The issuance was made in reliance on exemptions under Section 3(a)(9) or Section 4(a)(2) of the Securities Act of 1933 and/or Rule 506 of Regulation D. The transaction did not involve a public offering, general solicitation, or paid commissions.
Investor Verification Checklist
- Verify the total outstanding principal remaining on the $7,500,000 convertible note after the June 17, 2026 payment.
- Confirm the total number of shares outstanding post-issuance to assess dilution impact.
- Review the terms of the Securities Purchase Agreement (SPA) dated May 15, 2025, as amended on January 7, 2026, for future conversion triggers.
- Check subsequent filings for any cash flow implications related to the remaining note balance.